| 1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
-4,56 % |
+19,05 % |
-0,35 |
| 2 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
-5,05 % |
+19,87 % |
-0,36 |
| 3 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
-6,31 % |
+21,26 % |
-0,40 |
| 4 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-6,53 % |
+21,24 % |
-0,41 |
| 5 |
LU0317020203 |
Candriam Equities L Biotechnology, V - Capitalisation |
-6,86 % |
+21,08 % |
-0,43 |
|
|
| 21 |
LU2208649280 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse QL-acc, USD |
-10,69 % |
+22,21 % |
-0,58 |
|
|
| 79 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-12,84 % |
+12,45 % |
-1,20 |
| 80 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-38,14 % |
+31,56 % |
-1,28 |
| 81 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-38,19 % |
+31,55 % |
-1,28 |
| 82 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-16,04 % |
+14,16 % |
-1,28 |
| 83 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-16,62 % |
+14,16 % |
-1,33 |